CUTR: Cutera, Inc. Stock

SIC 3845 – Electromedical and Electrotherapeutic Apparatus

Valuation
Market Cap ($M) 47.17
Enterprise Value ($M) 360.99
Book Value ($M) -192.56
Book Value / Share -9.59
Price / Book -0.24
NCAV ($M) -269.33
NCAV / Share -13.42
Price / NCAV -0.18

Profitability (mra)
Return on Invested Capital (ROIC) -0.60
Return on Assets (ROA) -0.29
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 2.22
Current Ratio 3.24

Balance Sheet (mrq) ($M)
Current Assets 235.23
Assets 311.99
Liabilities 504.56
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 212.37
Operating Income -142.42
Net Income -150.83
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -137.64
Cash from Investing 137.19
Cash from Financing -2.57

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-14 13G/A Point72 Asset Management, L.P. 1.10 -81.23
02-13 13G/A Vanguard Group Inc 5.08 -18.04
02-09 13G/A Fmr Llc 0.06 -99.08
02-06 13G/A Integrated Core Strategies (us) Llc 4.10 -44.50
01-26 13G/A BlackRock Inc. 6.60 5.42
01-19 13G Rtw Investments, Lp 9.11 -1.57
12-29 13D/A Pura Vida Investments, Llc 6.37 18.68
12-27 13D/A Gamco Investors, Inc. Et Al 4.49 -15.76
06-13 13D/A Voce Capital Management LLC 4.90 -23.11

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-05-10 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One)
2024-05-10 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For fiscal year ended December 31, 2023 ☐ Transition Report Pursuant to Section 1
2024-03-05 10-Q/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A (Amendment No.1) (Mark One)
2024-03-05 10-Q/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A (Amendment No. 1) (Mark One)
2024-03-05 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One)
2023-08-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One)

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-17 154,567 593,154 26.06
2024-05-16 171,436 671,577 25.53
2024-05-15 275,153 219,813 125.18
2024-05-14 499,326 419,698 118.97
2024-05-13 145,751 607,446 23.99

(click for more detail)

Similar Companies
ATRI – Atrion Corporation AXNX – Axonics, Inc.
BVS – Bioventus Inc. CVRX – CVRx, Inc.
DXCM – DexCom, Inc.


Financial data and stock pages provided by
Fintel.io